EVERSANA ONCOLOGY Trademark
Trademark Overview
On Friday, August 18, 2023, a trademark application was filed for EVERSANA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the EVERSANA ONCOLOGY trademark a serial number of 98139189. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, April 9, 2024. This trademark is owned by Eversana Life Science Services, LLC. The EVERSANA ONCOLOGY trademark is filed in the Advertising, Business and Retail Services category with the following description:
Oncology and hematology product commercialization services for drug companies, namely, providing access to launch strategy, marketing strategy, commercialization model, and market access services
General Information
Serial Number | 98139189 |
Word Mark | EVERSANA ONCOLOGY |
Filing Date | Friday, August 18, 2023 |
Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
Status Date | Tuesday, April 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Oncology and hematology product commercialization services for drug companies, namely, providing access to launch strategy, marketing strategy, commercialization model, and market access services |
Classification Information
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, September 18, 2023 |
Primary Code | 035 |
First Use Anywhere Date | Monday, June 7, 2021 |
First Use In Commerce Date | Monday, June 7, 2021 |
Trademark Owner History
Party Name | Eversana Life Science Services, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Milwaukee, WI 53202 |
Trademark Events
Event Date | Event Description |
Tuesday, April 9, 2024 | ASSIGNED TO EXAMINER |
Monday, September 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 22, 2023 | NEW APPLICATION ENTERED |